HGEN / Humanigen to Present at BIO CEO & Investor Conference

Humanigen Inc shares have plummeted more than 90% over the past month, and now trades at a little over a penny per share, after the clinical-stage bio more_horizontal

Humanigen (NASDAQ: HGEN ) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements. According to a fili more_horizontal

Humanigen's (HGEN) shares surge after presenting promising early results of its Precision Approach to Chronic Myelomonocytic Leukemia study of lenzilu more_horizontal

Source: shutterstock.com/PhotobyTawat Humanigen (NASDAQ: HGEN ) stock is heading lower on Monday as investors react to a delisting notice from the Nas more_horizontal

The NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in hospitalized COVID-19 patients fails to meet the primary e more_horizontal

HC Wainwright downgraded Humanigen Inc (NASDAQ: HGEN) to Neutral from Buy and removed the price target based on the removal of COVID-19 from lenzil more_horizontal

Humanigen (HGEN) stock is falling hard on Wednesday following the release of preliminary results from a Covid-19 clinical trial. The post Why Is Human more_horizontal

Shares of Humanigen Inc. plunged 67.9% in premarket trading on Wednesday, the day after the company said a National Institutes of Health clinical tria more_horizontal